Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including lenacapavir—HIV’s ability to evolve resistance to the breakthrough antiviral.

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Researchers found that Zika virus induces cells to create connections, called tunneling nanotubes, that may enable the virus to replicate and spread from mother to fetus. UNIVERSITY PARK, Pa. — In ...

Human norovirus, a positive-strand RNA virus that is the leading cause of viral gastroenteritis accounting for an estimated 685 million cases and approximately 212,000 deaths globally per year, has no ...

Single-cell analysis helps uncover how the BK virus replicates, opening the door to new drug targets. BK polyomavirus (BKPyV) is a major cause of kidney transplant failure. Without a complete ...

A 13-year-old girl in British Columbia who was hospitalized with bird flu for several weeks late last year harbored a mutated version of the virus, according to a report published this week in the New ...

Ushikuvirus is a newly identified giant virus that infects amoebas, adding to a growing group of oversized viruses that scientists believe may have played an important role in the emergence of complex ...